Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2001;37:1251-1255

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lindgren, A.
Right arrow Articles by Tuomilehto, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lindgren, A.
Right arrow Articles by Tuomilehto, J.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Cancer
*High Blood Pressure
Related Collections
Right arrow Other hypertension
Right arrow Epidemiology

(Hypertension. 2001;37:1251.)
© 2001 American Heart Association, Inc.


Scientific Contributions

Cancer Incidence in Hypertensive Patients in North Karelia, Finland

Annamarja Lindgren; Eero Pukkala; Aulikki Nissinen; Vesa Kataja; Irma-Leena Notkola; Jaakko Tuomilehto

From the Department of Public Health and General Practice, University of Kuopio (A.L., A.N., I.-L.N.), Finland; Finnish Cancer Registry (E.P.), Helsinki, Finland; Department of Neurology (A.N.) and Department of Oncology (V.K.), Kuopio University Hospital, Finland; and Department of Epidemiology and Health Promotion, National Public Health Institute (J.T.), Helsinki, Finland.

Correspondence to Annamarja Lindgren, Department of Public Health and General Practice, University of Kuopio, PB 1627, 70211 Kuopio, Finland. E-mail Lindgren{at}hytti.uku.fi

Abstract—Cancer incidence of 20 529 hypertensive patients included in the community-based hypertension register of the North Karelia Project was determined. A total of 2511 incident cancer cases were obtained among the patients in record linkage with the nationwide Finnish Cancer Registry during the mean follow-up time of 16 years. The age-adjusted incidence rates per 100 000 person-years were 248.4 for men and 171.7 for women, which correspond to that of the general population in the area. The Cox regression model was used to analyze the effect of hypertension-related variables on cancer incidence. In men, the diastolic blood pressure was associated with an increased cancer risk but only in those who smoked >10 cigarettes per day. The functional diagnosis of hypertension (stage I, hypertension with no end-organ damage; stage II, hypertension with left cardiac hypertrophy; and stage III, hypertension with extracardiac organ damage) was associated with the increased risk significantly in men who used antihypertensive drugs at baseline. In women, the diastolic blood pressure was associated with an increased cancer risk in those who did not use antihypertensive drugs at baseline. The functional diagnosis of hypertension was associated with an increased risk only in those who smoked >10 cigarettes per day, but the number of women and cancer cases in this group was small. These results indicate a complex pattern of diastolic blood pressure, functional diagnosis, use of antihypertensive drugs, smoking, and gender in the cancer risk of hypertensive patients.


Key Words: blood pressure • cancer • antihypertensive agents • functional diagnosis • incidence • record linkage, medical




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. M. Harrison-Bernard, S. Dipp, and S. S. El-Dahr
Renal and blood pressure phenotype in 18-mo-old bradykinin B2R(-/-)CRD mice
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2003; 285(4): R782 - R790.
[Abstract] [Full Text] [PDF]